Blockchain Registration Transaction Record

Tonix Pharmaceuticals Awarded $34 Million Contract with U.S. Department of Defence

Tonix Pharmaceuticals CEO Dr. Seth Lederman announces $34 million contract with the Defense Threat Reduction Agency (DTRA) for the development of broad-spectrum antiviral agents, enhancing medical readiness for military personnel.

Tonix Pharmaceuticals Awarded $34 Million Contract with U.S. Department of Defence

The development of broad-spectrum antiviral agents has the potential to significantly impact the way viral infections are managed in military and possibly civilian populations. This news matters as it highlights the commitment to advancing medical readiness and protection for military personnel, addressing the evolving needs of the healthcare and defense sectors.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x6fc3fbec12a6cfb42cd951375f124feff51a15da6c8ed5584e901f08ba0b3ccc
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintgleeUWsd-fe5c2bb8d2d73a6b9590ba94c75aeb61